Tech Titans Take Center Stage as MSCI World ETF Faces a Pivotal 48 Hours

The iShares MSCI World ETF is entering a defining stretch, with the fate of its recent rally hinging on earnings reports from its two largest holdings. Microsoft and Apple are set to deliver quarterly results within a day of each other this week, and given that the technology sector alone accounts for more than a quarter of the fund’s portfolio, the stakes could hardly be higher.

Microsoft reports on April 29 for its fiscal third quarter of 2026. The stock is trading roughly 22% below its all-time high, a reflection of growing investor skepticism about the quality of its massive $625 billion cloud backlog. The market will be looking for concrete evidence that artificial intelligence products like Copilot and the Azure platform are translating into real revenue growth. TD Cowen has maintained a buy rating but trimmed its price target to $540.

Apple follows on April 30. The iPhone maker has guided for second-quarter revenue growth of 13% to 16%, which would land between $107.8 billion and $110.7 billion. The company has beaten consensus estimates in four of the past five years, but this earnings release is overshadowed by a leadership transition. On April 20, Apple announced that Tim Cook will step down as CEO on September 1, 2026, moving into the role of executive chairman. He will be succeeded by John Ternus, currently senior vice president of hardware engineering.

Financials Provide a Buffer

While the tech heavyweights prepare to open their books, the financial sector—the ETF’s second-largest weighting at over 16%—has already delivered strong results. JPMorgan Chase posted a record $50.5 billion in first-quarter revenue, a 10% year-over-year increase. Morgan Stanley saw a 16% gain, and Goldman Sachs reported double-digit growth as well. This strength underpins FactSet’s forecast for S&P 500 earnings growth of 12.5% in the first quarter, which would mark the longest such expansion in over a decade.

Should investors sell immediately? Or is it worth buying MSCI World ETF?

Structural Headwinds on the Horizon

Beyond the immediate earnings calendar, the ETF faces several structural challenges. In May 2026, MSCI will implement a revised free-float calculation methodology, which is expected to trigger more significant portfolio rebalancing than its previous review. The healthcare sector, which makes up roughly 10% of the fund, is bracing for U.S. import tariffs of up to 100% on pharmaceutical products, scheduled for late July 2026. FactSet has already trimmed its S&P 500 earnings growth forecast from 13.4% to 12.5%, partly due to downward revisions in healthcare.

Cost pressure is also mounting. Competitors such as Invesco and UBS now offer comparable MSCI World ETFs with annual fees of 0.05% and 0.06%, respectively. BlackRock’s iShares fund charges 0.24%—a premium the firm defends by pointing to its extremely low tracking error.

Japan Adds a Wild Card

A separate development is unfolding in Japan, where the government is funneling massive subsidies to chip developer Rapidus. The company is set to receive 631.5 billion yen by March 2027 as it aims to produce cutting-edge two-nanometer chips. Meanwhile, SoftBank, Sony, and Honda have launched a joint AI development initiative. Since all three are listed in the MSCI World Index, the ETF stands to benefit indirectly. Microsoft is also pouring billions into Japan’s AI infrastructure, adding another layer of exposure.

Technical Picture and What’s Next

The ETF is currently trading at $195, just shy of its 52-week high of $195.79. However, a relative strength index of 94.6 signals that the fund is deeply overbought. Whether the Microsoft and Apple results can justify that valuation will become clear within the next 48 hours. The next dividend payout is scheduled for June 15.